Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) — Cash Flow Reinvestment Rate
Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a Cash Flow Reinvestment Rate of 0.63x as of December 2025, reinvesting ₫135.54 Billion (capex ₫135.54 Billion ) from operating cash flow of ₫213.49 Billion. See Binh Dinh Pharmaceutical and Medical Equ free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Binh Dinh Pharmaceutical and Medical Equipment JSC Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for Binh Dinh Pharmaceutical and Medical Equipment JSC across 6 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Binh Dinh Pharmaceutical and Medical Equ.
Annual Cash Flow Reinvestment Rate for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)
Year-by-year capital reinvestment analysis for Binh Dinh Pharmaceutical and Medical Equipment JSC. See Binh Dinh Pharmaceutical and Medical Equ (DBD) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (VND) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.13x | ₫693.35 Billion | ₫615.19 Billion | ₫408.57 Billion | ▲ +13.3% |
| 2024 | 0.99x | ₫263.38 Billion | ₫264.73 Billion | ₫148.75 Billion | ▲ +17.5% |
| 2023 | 0.85x | ₫248.93 Billion | ₫293.99 Billion | ₫133.69 Billion | ▼ -41.9% |
| 2022 | 1.46x | ₫240.52 Billion | ₫165.01 Billion | ₫82.83 Billion | ▲ +14.3% |
| 2021 | 1.27x | ₫149.86 Billion | ₫117.57 Billion | ₫54.64 Billion | ▲ +273.1% |
| 2020 | 0.34x | ₫72.73 Billion | ₫212.91 Billion | ₫59.73 Billion | — |